Applications of 2,4-Dichloro-5-Fluoroaniline in Industrial Manufacturing

2,4-Dichloro-5-Fluoroaniline serves as a key intermediate in multiple specialty chemical sectors, particularly where halogenated aromatic amines are essential for downstream synthesis. Our manufacturing expertise enables bulk supply of this intermediate for use in regulated industrial processes where purity, compliance, and consistency are critical.

1. Agrochemical Active Ingredient Synthesis

Chemical manufacturers require this compound for the synthesis of selective herbicide and fungicide active ingredients in post-emergence crop protection agents. It provides a specific halogenation pattern that influences the bioactivity and environmental profile of phenoxy and triazole-based agrochemicals. Production plants introduce this material during the initial coupling or amination step, dictating molecular substitution and final efficacy profile for the target field application.

Industry compliance standards

• ISO 9001:2015 for quality management systems
• REACH (EC No 1907/2006) Registration—Substance Use in Agriculture
• Technical Grade ISO and FAO/WHO Specifications for Pesticide Ingredients
• Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) for US compliance

Typical usage ratio

• Ranging from 10% to 25% by mass of the total intermediate inputs depending on the targeted active molecule; formulation ratio often optimized based on synthetic route and yield requirements.

Downstream process integration

• Charged in the early stage of condensation reactions for herbicide and fungicide base structures; frequently involved in halogen-exchange reactions or direct amide coupling under controlled temperature and pressure in stainless steel reactors.

Final product types

• Select phenoxy and triazole herbicide technical concentrates
• Custom-formulated off-patent fungicidal actives for cereal and rice fields
• Pre-mix agricultural chemical blends for direct dilution and field application

2. Pharmaceutical Intermediate Production

Many pharmaceutical ingredient manufacturers leverage this intermediate in the route synthesis of novel quinoline and pyridine derivatives, used in the development of antimicrobial and anticancer drugs. It enters the process during the formation of complex aromatic scaffolds, ensuring selectivity in halogenation and minimizing impurities in the final API precursor stage.

Industry compliance standards

• Current Good Manufacturing Practice (cGMP) Standards (21 CFR Parts 210, 211)
• ICH Q7—Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
• USP, EP, and JP monographs for approval where applicable
• Regulatory filings for DMF (Drug Master File) where required by downstream API clients

Typical usage ratio

• Utilized at 5%–15% of the stepwise formulation mass for intermediates; exact ratio based on yield calculations and impurity profiling during scale-up validation.

Downstream process integration

• Introduced at the second- or third-stage cyclization reaction for building advanced molecular frameworks, especially in liquid-phase batch reactors under inert gas blankets to maintain purity.

Final product types

• Synthons for third-generation antibacterial APIs
• Advanced intermediates for oncological drug research
• Regulatory batch intermediates for custom pharma development (under non-GMP and cGMP regimes)

3. Dyes and Pigment Intermediate Manufacturing

Producers of specialty dyes and high-performance pigments rely on this compound as a controlled halogen source in the synthesis of azo, anthraquinone, and phthalocyanine dye intermediates. Its defined substitution pattern regulates final chromatic intensity and weatherfastness of the pigment dispersions manufactured for textile and plastics coloration.

Industry compliance standards

• ISO 14001:2015 for Environmental Management in Dye Production
• ZDHC MRSL v3.1 compliance for restricted substances in textile chemicals
• EN 71-3 standard for heavy metal limits in coloring materials for toys
• REACH Annex XVII compliance (restrictions on certain hazardous substances)

Typical usage ratio

• Used at 2%–8% of total batch input; ratio varies depending on color depth and substituent incorporation rates for mono- or bis-azo dye production.

Downstream process integration

• Processed via diazotization or nucleophilic aromatic substitution at the pre-condensation stage followed by coupling for pigment matrix integration; critical in continuous-flow reactors for large-scale productions.

Final product types

• High-performance azo dyes for polyester and acrylic fibers
• Granular organic pigments for automotive and industrial coatings
• Pigment dispersions for heat-stable plastics and masterbatches

4. Specialty Chemical Synthesis for Electronic Materials

Manufacturers of organic materials for printed circuit boards, display coatings, and photoresist applications utilize this intermediate to introduce functional halogen groups onto aromatic structures, essential for optimizing dielectric properties and etch resistance in microelectronics. The raw material enters high-purity batch reactors under dry-room conditions to prevent contamination and preserve strict electronics-grade quality.

Industry compliance standards

• IPC-4101B for base materials for printed boards
• RoHS Directive (2011/65/EU) for hazardous substance limitation
• IEC 61249-2-7 for halogen-free materials (for certain formulations)
• ISO 9001:2015 for quality assurance in specialty chemicals

Typical usage ratio

• Between 1.5%–6% of the specialty monomer feedstock, with the exact ratio determined by the electronic grade specification and functional group density required for final resin or coating.

Downstream process integration

• Fed during precursor polymer synthesis or small-molecule crosslinker production; implemented via controlled addition in jacketed glass-lined reactors to prevent contamination and meet trace metal specification limits.

Final product types

• Halogen-modified epoxy or polyimide resins for printed circuit laminates
• Photoresist monomers for integrated circuit lithography
• Specialty coatings for display panel barrier films

5. Fine Chemical Intermediate for Veterinary Medicine

Veterinary pharmaceutical manufacturers incorporate this aromatic amine intermediate in the synthesis pathway of active ingredients for animal health drugs, such as anti-infectives and parasiticides. Its structural specificity is crucial for the selectivity and safety profile of finished drugs for livestock and companion animals.

Industry compliance standards

• Veterinary Drug GMP (VD-GMP) standards (where implemented)
• VICH GLs (International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products)
• Pharmacopoeia requirements (Ph. Eur., USP-Vet, China Veterinary Pharmacopoeia as applicable)
• Local animal drug authority registration (such as FDA-CVM in the US, EMA in Europe, MOA in China)

Typical usage ratio

• 5%–12% of the total stepwise reactant mass in intermediate synthesis; tuned according to downstream route and yield optimization for specific veterinary APIs.

Downstream process integration

• Engaged during the aromatic amination or acylation reaction stages, commonly under nitrogen blanketing and monitored for byproduct control in multi-step batch synthesis workshops.

Final product types

• Active ingredient intermediates for veterinary anti-infective agents
• Key precursors for animal antiparasitic compound synthesis
• Custom veterinary pharmaceutical intermediates for contract manufacturing